GlassScriptPhysician profile
Taylor Lee Phillips
NPI 1871247718
$1,067.14
in general payments reported to CMS, 2019-2025
15 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $157 · 2023: $365 · 2024: $441 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $532 · Education: $378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $532.11 |
| Education | $378.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $321.84 | 2022-2024 | |
| Gilead Sciences, INC. | $127.06 | 2024 | Trodelvy |
| Janssen Biotech, INC. | $126.80 | 2023-2024 | Rybrevant, Tecvayli, Darzalex |
| Emd Serono, INC. | $102.24 | 2023-2025 | |
| Astellas Pharma US INC | $99.95 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $81.03 | 2023-2025 | Enhertu |
| Pfizer INC. | $38.87 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $32.37 | 2023-2025 | Keytruda, Lynparza |
| Puma Biotechnology, INC. | $31.66 | 2023-2024 | |
| Regeneron Healthcare Solutions, INC. | $23.33 | 2023 | Libtayo |
| Genentech USA, INC. | $19.59 | 2025 | Polivy |
| Pharmacosmos Therapeutics INC. | $17.51 | 2024 | Monoferric |
| E.R. Squibb & Sons, L.L.C. | $17.03 | 2024 | Opdivo |
| Takeda Pharmaceuticals U.S.A., INC. | $14.17 | 2024 | Fruzaqla |
| Genmab U.S., INC. | $13.69 | 2024 | Tivdak |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.